Archive - February 2021
Overuse of reliever medication for asthma a ‘major contributor’ to greenhouse gas emissions
Evgen Pharma recruits over 100 patients into COVID-19 trial
Novartis’ heart failure med Entresto scores an expanded approval in the US
‘Urgent action needed’ as NHS faces growing waiting lists
Taking Xeljanz? A new safety warning
bluebird bio temporarily suspends trials of sickle cell gene therapy LentiGlobin
BMS links up with Molecular Templates for oncology research collaboration
EU to begin new study programme investigating COVID-19 variants